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Abstract
GlycoproteinnonmetastaticmelanomaB(Gpnmb)isatypeItransmembranepro-
teinimplicatedincelldifferentiation,inﬂammation,tissueregeneration,andtumor
progression. Gpnmb, which is highly expressed in glioblastoma cells, is a potential
therapeutic target. However, little is known about its expression, cellular localiza-
tion, and roles in non-tumorous neural tissues. In this study, we examined Gpnmb
expression in the central nervous system of adult rats under both normal and in-
ﬂammatory conditions. Reverse transcription-polymerase chain reaction analysis
revealed that Gpnmb mRNA was expressed in the cerebrum, cerebellum, brain
stem, and spinal cord of normal adult rats. Immunoperoxidase staining revealed
that Gpnmb-immunoreactive cells were widely distributed in the parenchyma of
all brain regions examined, with the cells being most prevalent in the hippocam-
pal dentate gyrus, cerebellar cortex, spinal dorsal horn, choroid plexus, ependyma,
periventricular regions, and in layers II and III of the cerebral cortex. Double im-
munoﬂuorescence staining showed that these cells were co-stained most frequently
with the microglia/macrophage marker OX42, and occasionally with the radial glia
marker RC2 or the neuronal marker NeuN. Furthermore, an intraperitoneal in-
jection of bacterial endotoxin lipopolysaccharide increased the number of Gpnmb
and OX42 double-positive cells in the area postrema, which is one of the circum-
ventricular organs, indicating inﬁltration of hematogenous macrophages. These
results suggest that Gpnmb, which is expressed in microglia and macrophages in
non-tumorous neural tissues, plays an important role in the regulation of im-
mune/inﬂammatory responses.
Introduction
Glycoprotein nonmetastatic melanoma B (Gpnmb) is a type
I transmembrane protein implicated in various biological
processes, such as cell differentiation, inﬂammation, tissue
regeneration, and invasion and metastasis of malignant tu-
mors (Rose and Siegel 2010). Gpnmb contains a signal pep-
tideandpolycystickidneydiseaseIdomaininitsextracellular
portion, a part of which is released in a soluble form during
ectodomain shedding (Furochi et al. 2007a; Hoashi et al.
2010; Rose et al. 2010a). The cytoplasmic domain of Gpnmb
contains potential interaction sites for a number of signaling
molecules, including cyclin, mitogen-activated protein ki-
nase,andglycogensynthasekinase-3(Selim2009).Gpnmbis
localizednotonlytothecellsurfacemembrane,butalsotoen-
doplasmicreticulummicrosomesinosteoblasts(Abdelmagid
et al. 2008), melanosomes in melanoma cells (Hoashi et al.
2010), phagosomes in macrophages (Li et al. 2010), and
cytoplasmic vesicles in renal tubule-derived MDCT cells
(Patel–Chamberlin et al. 2011). Thus, Gpnmb is con-
s i d e r e dt of u n c t i o na sac e l ls u r f a c er e c e p t o r ,c e l la d -
hesion molecule, melanosomal protein, or soluble ligand
(Selim 2009). To date, its orthologs such as dendritic
cell heparan sulfate proteoglycan integrin-dependent lig-
and (DC-HIL; Shikano et al. 2001), osteoactivin (Safadi
et al. 2002), or hematopoietic growth factor inducible
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neurokinin-1 type (HGF-IN; Bandari et al. 2003) have been
identiﬁed in different species. In order to avoid complexity,
we hereafter use the term Gpnmb.
Since its initial identiﬁcation in human melanoma cells
(Weterman et al. 1995), Gpnmb has been considered a po-
tential therapeutic target for malignant tumors. Its expres-
sion is upregulated in various tumor cells, including gliomas
(Loging et al. 2000; Kuan et al. 2006; Tybruczy et al. 2010),
hepatomas (Onaga et al. 2003), and breast cancer (Rose and
Siegel 2010; Rose et al. 2010b). Gpnmb overexpression by
virus-mediated gene transfer in a human glioma cell line
resulted in a more invasive and metastatic phenotype, ac-
companied by enhanced expression of matrix metallopro-
teinase (MMP)-3 and MMP-9 (Rich et al. 2003). Tomihari
et al. (2010) demonstrated using a mouse model that Gp-
nmb inhibits the activation of melanoma-reactive T lym-
phocytes and thereby promotes invasion. Moreover, an anti-
Gpnmb monoclonal antibody that is conjugated with a cy-
totoxic agent has been subjected to clinical trials in pa-
tients with malignant glioma, breast cancer, and cutaneous
melanoma(Tseetal.2006;Pollacketal.2007;Qianetal.2008;
Naumovski and Junutula 2010; Rose and Siegel 2010;
Williams et al. 2010; Kuan et al. 2011).
In addition to tumor progression, Gpnmb is considered
to function in non-tumorous tissues. Its expression is up-
regulatedindamagedskeletalmuscles(Furochietal.2007b),
liver(Haralanova–Ilievaetal.2005),andkidneys(Nakamura
et al. 2007; Pahl et al. 2010; Li et al. 2010; Patel–Cahmberlin
et al. 2011), and fractured bones (Abdelmagid et al. 2010).
In vitro studies have shown that Gpnmb induces osteoblast
and osteoclast differentiation (Selim et al. 2003; Selim et al.
2007; Abdelmagid et al. 2008; Sheng et al. 2008). In den-
ervated mouse skeletal muscles, Gpnmb upregulates MMP-3
andMMP-9ininﬁltratingﬁbroblasts(Ogawaetal.2005).Gp-
nmb also functions as an inhibitor of T lymphocytes (Chung
etal.2007)andmacrophages(Ripolletal.2007).Theseﬁnd-
ings demonstrated the multiple roles of Gpnmb in normal
tissues.
However, with regard to the nervous system, Gpnmb ex-
pression has been exclusively investigated in glioblastomas.
Its expression in the normal brain is still unclear. Some stud-
iessteadilydetectedGpnmbmRNA(Safadietal.2002;Onaga
et al. 2003; Owen et al. 2003), but others not (Loging, et al.
2000;Shikanoetal.2001;Kuanetal.2006).Moreover,littleis
known about the regional distribution and cellular localiza-
tion of Gpnmb in the normal central nervous system (CNS).
Therefore,weexaminedGpnmbexpressioninCNSregionsof
normal adult rats by reverse transcription-polymerase chain
reaction(RT-PCR)andimmunohistochemicalanalyses.Fur-
thermore, to gain insight into the role of Gpnmb in the non-
tumorous CNS, we studied changes in Gpnmb expression in
inﬂamed brains.
Materials and Methods
Experimental animals
Adult Wister rats (200–300 g) were purchased from Charles
River Japan (Yokohama, Japan) and New Zealand white rab-
bits (approximately 4 kg) from CLEA Japan, Inc. (Tokyo,
Japan).TheexperimentalproceduresapprovedbytheGuide-
linefortheCareandUseofLaboratoryAnimalsinKanazawa
University. These animals were maintained in the Institute
for Experimental Animals of Kanazawa University Advanced
Science Research Center.
Injection of lipopolysaccharide (LPS)
LPSfromEscherichiacoliserotypeO127:B8(Sigma,St.Louis,
MO)wasdissolvedinsterilephosphate-bufferedsaline(PBS;
pH 7.4) and intraperitoneally injected at a dose of 0.1 mg/kg
of body weight.
RT-PCR
cDNA encoding the entire protein-coding sequence of
rat Gpnmb was obtained by RT-PCR using the follow-
ing set of primers: 5 -AGAGTCAAGCCCTGACTGGC-3 
(forward 1) and 5 -GAAGAGTGGGTTCCCAGTCA-3  (re-
verse 1). PCR was performed using a 50-μl reaction mix-
ture containing cDNA prepared from injured sciatic nerve
(Osamura et al. 2005; corresponding to 50 ng of to-
tal RNA), 1 × K O DF Xb u f f e r( T o y o b o ,O s a k a ,J a p a n ) ,
200 μM dNTPs, 200 nM of each primer, and 1 unit of KOD
FX DNA polymerase (Toyobo). The ampliﬁcation consisted
of 35 cycles of 10-sec denaturation at 98◦C, 30-sec annealing
at 60◦C, and 2-min extension at 68◦C. For TA cloning, 3 -A
overhangs were added to the ampliﬁed product by treating
it for 10 min at 72◦C in a reaction mixture containing 1 ×
ExTaq buffer (Takara Shuzo, Otsu, Japan), 75 μMdNTPs,2.5
mMMgCl2,and2.5unitsofExTaqDNApolymerase(Takara
Shuzo). The resulting fragment was cloned into a pCR2.1-
TOPO vector (Invitrogen, Carlsbad, CA) to yield pCRNMB,
which was veriﬁed by nucleotide sequencing.
For analysis of regional mRNA distribution, rats were
decapitated after deep anesthesia with diethyl ether and
chloral hydrate (500 mg/kg, intraperitoneally), and vari-
ous regions of CNS were dissected. Total cellular RNA
was extracted by the acid-phenol guanidium thiocyanate-
chloroform extraction method using RNA-Bee (Tel-Test,
Friendswood, TX) and reverse-transcribed using a kit (First-
Strand cDNA Synthesis Kit; Amersham Biosciences, Little
Chalfont, Buckinghamshire,United Kingdom) in a 15-μlr e -
action mixture containing 1 μg of total RNA, 45 mM Tris
(pH 8.3), 68 mM KCl, 15 mM dithiothreitol, 9 mM MgCl2,
0.08 mg/mL bovine serum albumin (BSA), 10 μg/mL ran-
dom hexanucleotide primers, and 1.8 mM dNTPs. After
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incubation for 1 h at 37◦C, the samples were diluted with
distilled water (185 μl), and heated for 5 min at 100◦C.
PCR was performed in a 20-μl reaction mixture contain-
ing cDNA products (corresponding to 5 ng of total RNA),
1 × Ampdirect-G/C buffer (Shimadzu, Kyoto, Japan), 200
μM dNTPs, 200 nM of each primer, 2.5 mM MgCl2,a n d1
unit of Ex Taq DNA polymerase (Takara Shuzo). The primer
pairsusedweredesignedasfollows(productsizeinparenthe-
ses): Gpnmb forward 2, 5 -TCCTCAGAGACCTCCCCATT-
3  and Gpnmb reverse 1 (993 bp); and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) forward, 5 -
TGAAGGTCGGTGTCAACGGATTTGGC-3  and GAPDH
reverse, 5 -CATGTAGGCCATGAGGTCCACCAC-3  (983
bp). Ampliﬁcation of Gpnmb and GAPDH cDNAs was per-
formed for 35 and 30 cycles, respectively. Each cycle of the
PCR program consisted of denaturation at 96◦Cf o r3 0s e c ,
annealingat60◦Cfor1min,andextensionat72◦Cfor1min.
PCR products were electrophoretically separated on a 1.2%
agarose gel and visualized by ethidium bromide staining.
Southern blot analysis
Afterelectrophoresis,PCRproductsweretransferredtoany-
lonmembrane(Zeta-Probe;Bio-RadLaboratories,Hercules,
CA) and hybridized with horseradish peroxidase (HRP)
conjugated probes. Probe labeling, hybridization, and de-
tection were performed using the enhanced chemilumi-
nescence (ECL) direct acid labeling and detection systems
(GE Healthcare, Piscataway, NJ) according to the manufac-
turer’s instructions. The probes used were the 460-bp NcoI
(1194)/NcoI(1656)fragmentfrompCRNMBandthe490-bp
NcoI(377)/ApaI(871)fragmentfrompCGAPDH(Osamura
et al. 2005); numbers in parentheses are in accordance with
the GenBank database (accession number NM 133298 for
rat Gpnmb and X02231 for rat GAPDH) and represent the
5 -terminalnucleotidegeneratedbyrestrictionendonuclease
digestion.
Antibody production and puriﬁcation
A synthetic peptide corresponding to the C-terminal region
of rat Gpnmb (amino acid residues 558–572, NCBI acces-
sion number NP 579832) was conjugated to keyhole limpet
hemocyanin (1 mg peptide/mg carrier protein; Calbiochem,
La Jolla, CA) using glutaraldehyde. Approximately 100 μg
of peptide in complete Freund’s adjuvant (Difco Laborato-
ries, Detroit, MI) was subcutaneously inoculated into two
New Zealand white rabbits. The rabbits were boosted ev-
ery two weeks and bled ﬁve to seven days after each boost.
Forafﬁnity-puriﬁcationofthecollectedantisera,thepeptide
(1 mg) was coupled to Afﬁ-Gel 10 (1 mL; Bio-Rad Labora-
tories) according to the manufacturer’s protocol. Antiserum
(5–10 mL) was incubated with the peptide-resin overnight
at 4◦C. After washing with 0.5 M MgCl2, bound antibodies
were eluted with 4 M MgCl2 and dialyzed against PBS (pH
7.4). Antibody concentration was determined by absorbance
at 280 nm using 1.38 as the extinction coefﬁcient.
Construction of an expression plasmid for
rat Gpnmb
pCRNMB was digested with HindIII and EcoRV and treated
with the Klenow fragment of DNA polymerase I. The result-
ing 1.9-kb fragment containing the entire protein-coding se-
quence of rat Gpnmb was ligated to XbaI-cleaved pEF-BOS
(a generous gift from Professor Nagata, Kyoto University,
Japan;MizushimaandNagata1990)aftertreatmentwiththe
KlenowfragmentofDNApolymeraseItoyieldanexpression
plasmid, pEF-RNMB.
Transfection and immunoﬂuorescence
staining
COS-7 cells cultured in Dulbecco’s modiﬁed Eagle’smedium
(Gibco-BRL, Grand Island, NY) containing 10% fetal calf
serum in a 5% CO2 atmosphere were transfected with pEF-
RNMB or pEF-BOS by the DEAE-dextran method (Golub
et al. 1989) and grown on poly-d-ornithine-coated glass
coverslips. After two days, cells were washed with ice-cold
PBS and sequentially incubated in (1) 2% paraformaldehyde
(PFA) in 0.1 M phosphate buffer (PB; pH 7.4) for 30 min
on ice; (2) PBS containing 0.3% Triton X-100 (PBS-T), three
changes, 5 min each; (3) blocking solution (PBS-T contain-
ing 1% BSA and 1.5% normal goat serum) for 1 h at room
temperature(RT);(4)afﬁnity-puriﬁedanti-Gpnmbprimary
antibodies (0.3 μg/mL in the blocking solution) overnight
at 4◦C; (5) PBS-T, six changes, 5 min each; (6) ﬂuorescein
isothiocyanate (FITC) conjugated goat anti-rabbit IgG anti-
body (1:1000 in the blocking solution; Jackson ImmunoRe-
search Laboratories, West Grove, PA) for 1 h at RT; and
(7) PBS-T, six changes, 5 min each. Next, coverslips were
mounted on glass slides with Vectashield (Vector Laborato-
ries, Burlingame, CA), sealed with nail polish and viewed
under a epiﬂuorescence microscope (IX71; Olympus, Tokyo,
Japan)usingU-MNIBA3(excitation,470–495nm;emission,
515–550 nm) and U-MWU2 (excitation, 330–385 nm; emis-
sion, 420 nm) ﬁlter cubes for visualization of FITC and 4 ,6-
diamidino-2-phenylindole (DAPI), respectively. Digital im-
ages were acquired using a computer-linked camera (DP71;
Olympus).TheobtainedimageswereprocessedusingAdobe
Photoshop CS2 (Adobe Systems, San Jose, CA).
Immunoblot analysis
Crude membranes were prepared from pEF-RNMB-
transfected, pEF-BOS-transfected, or non-transfected COS-
7 cells, and rat brains as follows. pEF-RNMB-transfected
or pEF-BOS-transfected COS-7 cells (10 μg) and non-
transfected cells were grown on 100-mm dishes as described
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above. After two days, transfected and non-transfected cells
were harvested by scraping in PBS containing 1% (w/v)
EDTA, pelleted by centrifugation at 400 × g for 10 min at
4◦C,andstoredat–80 ◦C.Thecellpelletsandfreshlydissected
rat brains were homogenized in 3 mL of a solution contain-
ing 0.25 M sucrose, 1 mM EDTA (pH 8.0), and protease
inhibitor cocktails (Complete Mini; Roche Applied Science,
Mannheim,Germany)usingaTeﬂon/glasshomogenizer.The
homogenateswerecentrifugedat1600×g for10minat4◦C,
and the supernatant was centrifuged at 84,000 × g for 30
min at 4◦C. The pellets were resuspended in 3 mL of 50 mM
Tris-HCl and 1 mM EDTA and recentrifuged at 84,000 × g
for 30 min at 4◦C. The obtained pellets were resuspended
in 0.1% SDS. Protein concentration was estimated by the
BCA protein assay kit (Thermo Scientiﬁc, Rockford, IL) us-
ingBSAasastandard.Membranepreparations(3or20μgof
protein) were fractionated on SDS-polyacrylamide gels and
electrophoretically transferred to polyvinylidene diﬂuoride
membranes(Millipore,Bedford,MA).Themembraneswere
stainedwith0.1%CoomassieBrilliantBlueR-250(CBB)con-
taining 10% acetic acid and 40% methanol, photographed,
and rinsed in 100% methanol. Next, the membranes were
blocked for 1 h at RT in PBS containing 0.1% Tween 20, 5%
skimmeddrymilk,1%BSA,and5%normalhorseserum,fol-
lowed by overnight incubation at 4◦C with anti-Gpnmb an-
tibodies(0.3μg/mL)intheblockingsolution.Theblotswere
washed and incubated with HRP-conjugated donkey anti-
rabbit IgG antibody (1:3000; GE Healthcare). Immunore-
active (IR) bands were detected by chemiluminescence on
X-ray ﬁlm (RX-U; Fuji Photo Film, Tokyo, Japan) using ECL
reagents (GE Healthcare). Images were obtained using an
image scanner (ES2200; Seiko Epson, Nagano, Japan) and
Adobe Photoshop software.
Immunoperoxidase staining
Rats were transcardially perfused with PBS followed by per-
fusion with a ﬁxative containing 4% PFA in 0.1 M PB after
deepanesthetiawithdiethyletherandchloralhydrate.Brains
wereremovedimmediatelyandpostﬁxedinthesameﬁxative
overnight at 4◦C and then cryoprotected for two days at 4◦C
with30%sucrosein0.1MPB.Sectionsatathicknessof16or
18 μm were cut using a cryostat and collected in PBS. Free-
ﬂoating sections were sequentially incubated in (1) blocking
solution (PBS containing 0.3% Triton X-100, 1% BSA, and
1.5% normal goat serum) for 1 h at 4◦C; (2) afﬁnity-puriﬁed
anti-rat Gpnmb antibodies (0.3 μg/mL in the blocking so-
lution) overnight at 4◦C; (3) PBS containing 0.3% Triton
X-100, three changes, 5 min each; (4) biotinylated goat-anti
rabbit IgG (1:2000; Vector Laboratories) in the blocking so-
lution for 1 h at RT; (5) PBS containing 0.3% Triton X-
100, three changes, 5 min each; (6) ExtrAvidin-Peroxidase
(1:1000; Sigma) in PBS containing 0.3% Triton X-100 for
Table 1. List of antibodies used in this study.
Antibody Species/Isotype Source, Catalog number Dilution Immunogen
Primary antibody
Calbindin D-28K Mouse monoclonal IgG1 Swant, 300 1:100 Chicken gut-derived cal-
bindin D28K
ED1 (CD68) Mouse monoclonal IgG1 AbD Serotec, MCA341GA 1:100 Rat spleen cells
GFAP (Clone G-A-5) Mouse monoclonal IgG1 Sigma, G 3893 1:400 Pig spinal cord-derived
GFAP
NeuN Mouse monoclonal IgG1 Millipore, MAB377 1:100 Puriﬁed cell nuclei from
mouse brain
NG2 Mouse monoclonal IgG1 Millipore, MAB5384 1:100 Cell line expressing a trun-
cated form of NG2
OX6 (MHC Class II Ia) Mouse monoclonal IgG1 abcam, ab6403 1:400 Rat thymocyte membrane
glycoprotein
OX42 (CD11b/c) Mouse monoclonal IgG2a abcam, ab1211 1:200 Rat macrophages
Radial glial cell marker-2 (Clone
RC2)
Mouse monoclonal IgMλ Millipore, MAB5740 1:200 Embryonic rat brain
S-100 (β-subunit; Clone SH-B1) Mouse monoclonal IgG1 Sigma S 2532 1:1000 Bovine brain S-100β
Secondary antibody
FITC-conjugated anti-rabbit IgG Goat Jackson ImmunoResearch,
111-095-144
1:500
Texas Red-conjugated anti-mouse
IgG
Goat Molecular Probes, 00862 1:500
Alexa Fluor 594-conjugated anti-
mouse IgM
Goat Molecular Probes, A21044 1:500
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30 min at RT; (7) PBS containing 0.3% Triton X-100, ﬁve
changes, 5 min each; and (8) working solution of the metal-
enhanced diaminobenzidine (DAB) substrate kit (Thermo
Scientiﬁc). After six rinses in distilled water, sections were
mounted on untreated clean glass slides and covered with
mounting medium (Aquatex; Merck, Darmstadt, Germany)
andaglasscoverslip.Photomicrographswereobtainedusing
a light microscope (BZ-8000; Keyence, Osaka, Japan). Nega-
tive controls were obtained by preadsorbing antibodies with
an excess (30 mM) of the synthetic peptides.
Multiple-label immunoﬂuorescence
Sections (16 μm) were prepared by the same method
as for immunoperoxidase staining and sequentially incu-
bated overnight at 4◦C with rabbit anti-Gpnmb antibody
(1 μg/mL) and mouse monoclonal antibodies in the block-
ing buffer; the details and ﬁnal concentrations are given in
Table 1. After rinsing, sections were incubated for 1 h at RT
with a mixture of appropriate ﬂuorescence-conjugated sec-
ondaryantibodies(Table1)intheblockingsolution.Sections
were examined under a Keyence BZ-9000 microscope using
OP-66836 BZ ﬁlter GFP-BP (excitation, 440–470 nm; emis-
sion,535–550nm),OP-66838BZﬁlterTexasRed(excitation,
540–560nm;emission,630–660nm),andOP-66834BZﬁlter
DAPI-BP(excitation,340–360nm; emission,450–460nm).
Staining with isolectin B4 (IB4)
Sections were incubated with biotin-conjugated IB4 (1:100;
Sigma) during primary antibody incubation and with Texas
Red-conjugated streptavidin (1:100; GE Healthcare) during
secondary antibody reaction.
Results
Gpnmb mRNA expression in rat brain
To examine whether Gpnmb mRNA was expressed in rat
CNS, we ﬁrst performed RT-PCR analysis. Primers were de-
signed to distinguish between the ampliﬁed product from
c D N Aa n da na m p l i ﬁ e dp r o d u c td e r i v e df r o mc o n t a m i n a t -
ing genomic DNA. As shown in Fig. 1A, sense and antisense
primers were made to recognize exons 6 and 11, respec-
tively. PCR products from cDNA and genomic DNA were
predicted to be 993 bp and 4.4 kb, respectively. Furthermore,
speciﬁcity of PCR products was conﬁrmed by Southern blot
analysisusinganinternalprobe(Fig.1A).GpnmbmRNAex-
pressionwasdetectedinallbrainregionsexamined;GAPDH
cDNAwasusedtoconﬁrmtheintegrityofRNApreparations
(Fig. 1B).
Antibody validation
ToexamineGpnmbexpressionattheproteinlevel,wegener-
ated a polyclonal antibody against rat Gpnmb by immuniz-
Figure 1. Reverse transcription-polymerase chain reaction (RT-PCR)
analysis of Gpnmb mRNA in CNS of adult rats. (A) Schematic represen-
tation of the recognition sites of Gpnmb-speciﬁc PCR primers (arrows),
the predicted sizes of the ampliﬁcation products, and the probe used for
Southern blot analysis. The exon–intron organization is depicted based
on GenBank accession number NC 005103. Exons are indicated by rect-
angles and introns and 5
 -a n d3
 -ﬂanking regions are indicated by lines.
Open and ﬁlled rectangles represent untranslated and protein-coding
regions, respectively. (B) Photomicrographs of Southern blot analysis.
Total cellular RNA from the indicated regions was subjected to RT-PCR.
The ampliﬁed cDNAs were separated on 1.2% agarose gels, transferred
to nylon membranes, and hybridized with HRP-conjugated Gpnmb- or
GAPDH-speciﬁc probes. The absence of reverse transcriptase is indicated
as [RT (-)]. GAPDH cDNA was ampliﬁed as a positive control. Size markers
are given on the right.
ing rabbits with a synthetic peptide corresponding to the C-
terminal region. Immunoﬂuorescence staining revealed that
Gpnmb-immunoreactivity (IR) was localized to lysosome-
like structures in cDNA-transfected COS-7 cells, but not
in mock-transfected or non-transfected cells (Fig. 2A). Im-
munoblot analyses using the obtained antibody detected a
major band of 68 kD and a smear from 68 to 95 kD in
cDNA-transfected COS-7 cells, but not in mock-transfected
and non-transfected COS-7 cells (Fig. 2B). The 68 kD band
agrees well with the predicted molecular mass of rat Gpnmb,
and the smear is most likely a glycosylated form. Further-
more, the antibodies recognized two main bands of 68 and
150 kD in a crude membrane fraction prepared from the en-
tire brain (Fig. 2C). These bands were completely abolished
by preadsorption of the antibody with the peptide used for
immunization (Fig. 2C).
Gpnmb-IR in normal rat brain
Cerebral cortex
Gpnmb-IR was observed in all layers of the cerebral cor-
tex, but staining was most prominent in layers II and III
(Fig. 3A). IR was abolished by preadsorption of the primary
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Figure 2. Antibody validation. (A) COS-7 cells that were transfected
with an expression plasmid for Gpnmb (Gpnmb) or an empty vec-
tor (Mock) and non-transected cells (-) were stained with anti-Gpnmb
antibody and visualized with FITC-conjugated secondary antibody
(green). DAPI was used to stain cell nuclei (blue). Note that Gpnmb-
immunoreactivity (IR) is detected only in Gpnmb cDNA-transfected cells.
Scale bar, 50 μm. (B) Immunoblot showing reactivity of the antibody
with rat Gpnmb expressed in COS-7 cells. The crude membranes (3 μg)
obtained from Gpnmb cDNA-transfected, mock-transfected, and non-
transfected COS-7 cells (-) were subjected to 9% SDS-PAGE, transferred
to a nylon membrane, and probed with the anti-Gpnmb antibody pre-
pared in this study. (C) Crude membranes from adult rat brains (20 μg)
were subjected to 7.5% SDS-PAGE and transferred to a nylon mem-
brane. The membrane was cut into two parts, and each was probed
separately with the anti-Gpnmb antibody before and after adsorption
(ads, – and ads, +) with the antigenic peptide. Membranes stained with
CBB are presented as a loading control in both (B)a n d( C); the positions
of molecular weight markers are indicated on the left.
antibody with the peptide used for immunization (Fig. 3B).
Some of the Gpnmb-IR cells appeared to have ﬁne processes
(Fig. 3C, D). Double immunoﬂuorescence staining revealed
that Gpnmb-IR cells in layers II and III were positive for
the microglia/macrophage markers OX42 (Fig. 4A) and IB4
(Fig. 4B). Although less frequently, some Gpnmb-IR cells
were co-stained for the radial glial lineage marker RC2
(Fig. 4C). In contrast, no co-staining was observed with an-
tibodies to the astrocyte lineage markers glial ﬁbrillary acidic
protein (GFAP; Fig. 4D) and protein S-100β (Fig. 4E) and
the neuronal marker NeuN (Fig. 4F). This tendency was the
same in other layers, except that occasional co-staining with
N e u Nw a sd e t e c t e di nl a y e rV I( F i g .S 1 ) .
Figure 3. Distribution of Gpnmb-IR in rat cerebral cortex. (A, B) Layers
I–VI of the cortex. Sections obtained from adult rats were stained with
anti-Gpnmb antibody before [ A, ads (-)] or after [ B, ads (+)] adsorption
with the antigenic peptide and then visualized with DAB. (C, D) Higher
magniﬁcation views of Gpnmb-IR cells in layers II and VI are shown,
respectively. Scale bars: A, B, 50 μm; C, D, 30 μm.
Hippocampus
Gpnmb-IR was observed throughout the hippocampus
(Fig. 5A). IR was abolished by the primary antibody that
was preadsorbed with the peptide used for immunization
(Fig. 5B). IR in the CA1 segment (Fig. 5C) and dentate gyrus
(Fig.5F)wasstrongerthanthatobservedintheCA2andCA3
segments (Fig. 5D, E). With double ﬂuorescence staining,
Gpnmb-IR cells co-stained with OX42 or IB4 were observed
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Figure 4. Characterization of Gpnmb-IR cells in cortical layers
II–III with multiple markers. Sections were double-stained for
Gpnmb (FITC, green) and the indicated markers (Texas Red, red).
Note that Gpnmb-IR cells are co-stained with OX42, IB4, and
RC2 (arrows). Scale bars: A, 10 μm; B – F, 30 μm.
in the polymorphic cell layer (Fig. 6A, B), but no co-staining
with GFAP or NG2 was observed (Fig. 6C, D). A fraction of
Gpnmb-IR cells in the granule cell layer of the dentate gyrus
was positive for NeuN (Fig. 6E).
Cerebellum
In the cerebellum, cell bodies in the Purkinje cell layer and
ﬁne processes in the molecular layer were stained (Fig. 7A,
C).Stainingwasabolishedbypreadsorbingtheprimaryanti-
bodywiththepeptideusedforimmunaization(Fig.7B).The
Gpnmb-IR cells were co-stained with anti-GFAP (Fig. 7D)
andanti-RC2(Fig.7E)antibodies,butnotatallwithananti-
bodyagainstcalbindinD-28K,aspeciﬁcmarkerforPurkinje
neurons (Fig. 7F). Therefore, we concluded that Gpnmb-IR
cells were Bergmann glial cells.
Spinal cord
In the spinal cord, Gpnmb-IR was observed more frequently
in the gray matter (Fig. 8A, C) than in the white matter
(Fig. 8A, D). Staining was abolished when the primary
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Figure5. DistributionofGpnmb-IRinrathippocampus.(A,B)Lowmag-
niﬁcation images. Sections obtained from adult rats were stained with
anti-Gpnmb antibody before [ A, ads (-)] or after [ B, ads (+)] adsorption
with the antigenic peptide, and visualized with DAB. Continuous images
were combined with Imagejoint program. (C – F) Immunoreactive cells
in the indicated regions. Scale bars: A, B, 100 μm; C – F, 30 μm.
antibody was preadsorbed with the antigen peptide (Fig.
8B). In particular, intense staining was observed in the su-
perﬁcial layers of the dorsal horn and large neurons in the
anteriorandlateralhorns(Fig.8A,C).Gpnmb-IRcellsinthe
dorsal horn were costained with OX42 (Fig. 8E) and NeuN
(Fig. 8F).
Other areas
Prominent Gpnmb-IR was observed in the choroid plexus
(Fig. 9A), ependyma (Fig. 9B), median preoptic nucleus
(Fig. 9C), periventricular area surrounding the third ven-
tricle (Fig. 9D), olfactory bulb (Fig. S2A–D), and striatum
( F i g .S 3 A – C ) .T h e s ec e l l sw e r ec o n ﬁ r m e dt ob ep o s i t i v ef o r
the microglia/macrophage markers in the choroid plexus
(Fig.9E),olfactorybulb(Fig.S2E,F),andstriatum(Fig.S3C,
D). The relative intensity of Gpnmb-IR in major regions of
the rat CNS is summarized in Table S1.
Gpnmb-IR in inﬂamed rat brain
Since Gpnmb-IR cells in normal CNS were mostly positive
forthemicroglia/macrophagelineagemarkers,wefurtherex-
aminedwhetherinﬂammatorystimulationhadanyeffectson
these cells. After intraperitoneal injection of bacterial endo-
toxin(LPS),weobservedthatGpnmb-IRintheareapostrema
was prominent compared with that in rats injected with PBS
(Fig. 10A). This change became obvious 8 h after the LPS
injection and was more widespread after 24 h (Fig. 10A).
Gpnmb-IR cells were positive for OX42 (Fig. 10B) and ap-
peared to be in contact with vessels (Fig. 10A, B). Gpnmb-IR
was localized to cytoplasmic vesicles (Fig. 10B). These ob-
servations suggest that macrophages inﬁltrated from blood
vessels in this systemic inﬂammation model.
Discussion
The main ﬁndings of this study were as follows: (1) Gp-
nmb mRNA was widely present in normal CNS of adult rats,
Figure 6. Characterization of Gpnmb-IR cells in the hippocampal den-
tate gyrus. Sections were double-stained for Gpnmb (green) and the
indicated markers (red). Note that Gpnmb-IR cells were co-stained with
OX42, IB4, or NeuN (arrows). Scale bars: A, 10 μm; B – E, 30 μm.
(2) Gpnmb-IR cells in the normal CNS are preferentially
stained with microglia/macrophage markers, and occasion-
ally with the radial glial marker RC2 and neuronal nuclei
marker NeuN, and (3) systemic LPS administration evoked
an increase in Gpnmb-IR in the area postrema. These data
demonstrate for the ﬁrst time that Gpnmb is expressed not
onlyinbraintumorcells,butalsoinnormalCNSandprovide
insights into the roles of Gpnmb in CNS.
Microglial cells are known to produce various cytokines,
neurotrophic factors, proteases, and gaseous neuromodula-
tors that regulate multiple processes, including maintenance
of the CNS structure, immune/inﬂammatory responses, and
regulation of neuronal networks (Kettenmann et al. 2011).
Previous in vitro studies have demonstrated that Gpnmb
canfunctionasananti-inﬂammatoryregulatorbyinhibiting
the activation of T lymphocytes (Chung et al. 2007) or by
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Figure 7. Gpnmb-IR in rat cerebellum. (A – C) Immunoperoxidase stain-
ing of rat cerebellar cortex. (A, B) Low magniﬁcation images. Sections
obtained from adult rats were stained with the anti-Gpnmb antibody
before [ A, ads (-)] or after [ B, ads (+)] adsorption with the antigenic
peptide and then visualized with DAB. (C) Gpnmb-IR in cell bodies in
the Purkinje cell layer and processes in the molecular layer are indicated
by arrows and arrowheads, respectively. (D – F) Double immunoﬂuo-
rescence staining of rat cerebellar cortex. Sections from adult rats were
double-stained for Gpnmb (green) and the indicated markers (red). Note
that Gpnmb-IR is co-localized with GFAP (D) and RC2 (E) but not with
calbindin D-28K (F). ML, molecular layer; PCL, Purkinje cell layer; GCL,
granule cell layer. Scale bars: A, B, 30 μm; C – F, 20 μm.
reducing the secretion of proinﬂammatory cytokines from
macrophages (Ripoll et al. 2007). Therefore, it is possible
that Gpnmb produced by microglia acts on immune effector
cells and alleviates excessive proinﬂammatory responses in
the CNS.
In addition, we found that an intraperitoneal injection of
LPS increased Gpnmb and OX42 double-positive cells in the
area postrema. Because the increase was detectable 8 h after
the injection, it is possible that blood-borne macrophages
expressing Gpnmb inﬁltrated from systemic circulation and
participated in the immune/inﬂammatory responses. The
area postrema, which is an interface between the immune
systemandbrain,contributestoautonomiccontrolofbrain-
mediated host defense responses (Goehler et al. 2006). In
previous studies, systemic LPS administration upregulated
tumor necrosis factor-α (Breder et al. 1994) and interleukin-
6( V a l l i ` eres and Rivest 1997) mRNA levels within 8 h. We
assume that Gpnmb produced by inﬁltrating macrophages
may counteract or decrease the actions of these proinﬂam-
matory cytokines.
Recently, a genome-wide association study identiﬁed the
human Gpnmb gene on chromosome 7p15 as a risk locus
for Parkinson’s disease (International Parkinson’s Disease
Genomics Consortium (IPDGC) and Wellcome Trust Case
Control Consortium 2 (WTTCCC2) 2011). Considering the
present observation that Gpnmb-IR is detectable in ED1- or
OX42-positivecellsinthestriatum(Fig.S3),itistemptingto
Figure 8. Distribution of Gpnmb-IR in rat spinal cord. (A – D)I m -
munoperoxidase staining before [ A, ads (-)] or after [ B, ads (+)] ad-
sorption with the antigenic peptide. (C, D) Regions enclosed in the re-
spective dotted line boxes (A, upper and lower) are high magniﬁcation
views. SG, substantia gelatinosa; AF, anterior funiculus. (E, F) Double
immunoﬂuorescence staining. Gpnmb-IR cells are co-stained with OX42
(E) and NeuN (F), as indicated by arrows. Scale bars: A, B, 100 μm ;C–
E, 20 μm; F, 30 μm.
postulatethatGpnmbmayexertananti-inﬂammatoryeffect
during the degeneration of nigrostriatal neurons.
In addition to macrophage/microglia lineage cells, we de-
tectedGpnmb-IRinependymal,Bergmannglial,andNeuN-
positive neuronal cells. Ependymal cells, like astrocytes, can
be generated from radial glia (Spassky et al. 2005; Wang and
Bordey 2008) and express GFAP (Doetsch et al. 1997; Liu
et al. 2006; Wang and Bordey 2008). Bergmann glial cells
are radial glia that persist in the adult cerebellum without
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Figure 9. Gpnmb-IR in periventricular areas in rat brain. (A) Choroid
plexus (ChP). (B) Ependymal cells (Epe). (C) Median preoptic nucleus
(MnPO). (D) A region surrounding the third ventricle (3V). (E) Double im-
munoﬂuorescence staining of the choroid plexus in the lateral ventricle.
Gpnmb-IR cells are co-stained with OX42. Scale bars: A, B, E, 20 μm; C,
50 μm; D, 30 μm.
differentiating into mature astrocytes (Kriegstein and G¨ otz
2003; Rakic 2003; Wang and Bordey 2008) and regarded as
specialized astrocytes (Rakic 2003). Although these GFAP-
positive cells are originated from radial glia, Gpnmb-IR was
detected only in ependymal and Bergmann glial cells, but
not in the majority of astrocytes. One possible explanation
for this difference is that Gpnmb expression in ependymal
and Bergmann glial cells may take place after commitment
to terminal differentiation. Although the nature and onto-
g e n i co r i g i no fG p n m ba n dN e u Nd o u b l e - p o s i t i v ec e l l sa r e
currently unclear, Gpnmb-IR in hippocampal granular cell
neurons could be explained as a remnant of radial glia, from
which these neurons originated (Kriegstein and G¨ otz 2003).
Elucidation of the role of Gpnmb in these cell types requires
more detailed characterization during development.
Inconclusion,thepresentresultsindicatethatGpnmbwas
expressed in microglia/macrophage and radial glial lineage
cells in non-tumorous neural tissues. It is therefore conceiv-
able that Gpnmb-targeted therapies may have detrimental
effects on these cell types. More importantly, our ﬁndings
raise the possibility that Gpnmb may serve as a novel reg-
ulator of immune/inﬂammatory responses in CNS. Future
studies are needed to clarify the role of Gpnmb in im-
mune/inﬂammatory responses underlying traumatic nerve
injury and neurodegenerative diseases, such as multiple scle-
rosis, Parkinson’s disease, and Alzheimer’s disease.
Figure 10. Gpnmb-IR in rat area postrema following endotoxin treat-
ment. Adult rats were injected intraperitoneally with LPS or PBS. After
8 or 24 h, rats were perfused with ﬁxative, and sections obtained were
stained with anti-Gpnmb antibody. (A) Immunoperoxidase staining. Re-
gions enclosed in dotted line boxes are high magniﬁcation views (LPS,
right). Scale bars: LPS (left) and PBS, 50 μm; LPS (right) and PBS, 30 μm.
(B) Triple immunoﬂuorescence staining for Gpnmb (green), OX42 (red),
and DAPI (blue). Asterisks denote vessels. Scale bar, 10 μm.
Acknowledgments
We thank O. Takahashi for high-magniﬁcation ﬂuorescence
microscopy. This work was supported in part by grants from
theMinistryofEducation,Culture,Science,SportsandTech-
nology of Japan.
References
Abdelmagid, S. M., M. F. Barbe, M. C. Rico, S. Salihoglu, I.
Arango-Hisijara, A. H. Selim, M. G. Anderson, T. A. Owen, S.
N. Popoff, and F. F. Safadi. 2008. Osteoactivin, an anabolic
factor that regulates osteoblast differentiation and function.
Exp. Cell Res. 314:2334–2351.
A b d e l m a g i d ,S .M . ,M .F .B a r b e ,M .H a d j i a r g y r o u ,T .A .O w e n ,R .
Razmpour, S. Rehman, S. N. Popoff, and F. F. Safadi. 2010.
Temporal and spatial expression of osteoactivin during
fracture repair. J. Cell. Biochem. 111:295–309.
Bandari, P. S., J. Qian, G. Yehia, D. D. Joshi, P. B. Maloof, J.
Potian, H. S. Oh, P. Gascon, J. S. Harrison, and P. Rameshwar.
2003. Hematopoietic growth factor inducible neurokinin-1
type: a transmembrane protein that is similar to neurokinin 1
interacts with substance P. Regul. Pept. 111:169–178.
94 c   2012 The Authors. Published by Wiley Periodicals, Inc.J.-J. Huang et al. Gpnmb Expression in Normal and Inﬂamed CNS
B r e d e r ,C .D . ,C .H a z u k a ,T .G h a y u r ,C .K l u g ,M .H u g i n i n ,K .
Yasuda, M. Teng, and C. B. Saper. 1994. Regional induction of
tumor necrosis factor α expression in the mouse after systemic
lipopolysaccharide administration. Proc. Natl. Acad. Sci.
U.S.A. 91:11393–11397
C h u n g ,J . - S . ,K .S a t o ,I .I .D o u g h e r t y ,P .D .C r u zJ r ,a n dK .
Ariizumi. 2007. DC-HIL is a negative regulator of T
lymphocyte activation. Blood109:4320–4327.
D o e t s c h ,F . ,J .M .G a r c ´ ıa-Verdugo, and A. Alvarez-Buylla. 1997.
Cellular composition and three-dimensional organization of
the subventricular germinal zone in the adult mammalian
brain. J. Neurosci. 17:5046–5061.
Furochi, H., S. Tamura, K. Takeshima, K. Hirasaka, R. Nakao, K.
Kishi, and T. Nikawa. 2007b. Overexpression of osteoactivin
protects skeletal muscle from severe degeneration caused by
long-term denervation in mice. J. Med. Invest. 54:248–254.
Furochi, H., S. Tamura, M. Mameoka, C. Yamada, T. Ogawa, K.
H i r a s a k a ,Y .O k u m u r a ,T .I m a g a w a ,S .O g u r i ,K .I s h i d o h ,e ta l .
2007a. Osteoactivin fragments produced by ectodomain
shedding induce MMP-3 expression via ERK pathway in
mouse NIH-3T3 ﬁbroblasts. FEBS Lett. 581:5743–5750.
Goehler, L. E., A. Erisir, and R. P. A. Gaykema. 2006.
Neural-immune interface in the rat area postrema.
Neuroscience140:1415–1434.
Golub, E. I., H. Kim, and D. J. Volsky. 1989. Transfection of DNA
into adherent cells by DEAE-dextran/DMSO method increases
drastically if the cells are removed from surface and treated in
suspension. Nucleic Acids Res. 17:4902.
Haralanova-Ilieva, B., G. Ramadori, and T. Armbrust. 2005.
Expression of osteoactivin in rat and human liver and isolated
rat liver cells. J. Hepatol. 42:565–572.
Hoashi, T., S. Sato, Y. Yamaguchi, T. Passeron, K. Tamaki, and V.
J. Hearing. 2010. Glycoprotein nonmetastatic melanoma
protein b, a melanocytic cell marker, is a melanosome-speciﬁc
and proteolytically released protein. FASEB J. 24:1616–1629.
International Parkinson’s Disease Genomics Consortium
(IPDGC), and Wellcome Trust Case Control Consortium 2
(WTTCCC2). 2011. A two-stage meta-analysis identiﬁes
several new loci for Parkinson’s disease. PLoS Genet.
7:e1002142.
Kettenman, H., U.-K. Hanisch, M. Noda, and A. Verkhratsky.
2011. Physiology of microglia. Physiol. Rev. 91:461–553.
K r i e g s t e i n ,A .R . ,a n dM .G¨ otz. 2003. Radial glia diversity: a
matter of cell fate. Glia43:37–43.
Kuan, C.-T., K. Wakiya, J. M. Dowell, J. E. Herndon II, D. A.
Reardon, M. W. Graner, G. J. Riggins, C. J. Wikstrand, and D.
D. Bigner. 2006. Glycoprotein nonmetastatic melanoma
protein B, a potential molecular therapeutic target in patients
with glioblastoma multiforme. Clin. Cancer Res.
12:1970–1982.
Kuan, C.-T., K. Wakiya, S. T. Keir, J. Li, J. E. Herndon II, I. Pastan,
and D. D. Binger. 2011. Afﬁnity-matured anti-glycoprotein
NMB recombinant immunotoxins targeting malignant
gliomas and melanomas. Int. J. Cancer129:111–121.
L i ,B . ,A .P .C a s t a n o ,T .E .H u d s o n ,B .T .N o w l i n ,S . - L .L i n ,J .V .
Bonventure, K. D. Swanson, and J. S. Dufﬁeld. 2010. The
melanoma-associated transmembrane glycoprotein Gpnmb
controls trafﬁcking of cellular debris for degradation and is
essential for tissue repair. FASEB J. 24:4767–4781.
L i u ,X . ,A .J .B o l t e u s ,D .M .B a l k i n ,O .H e n s c h e l ,a n dA .B o r d e y .
2006. GFAP-expressing cells in the postnatal subventricular
zone display a unique glial phenotype intermediate between
radial glia and astrocytes. Glia54:394–410.
Loging, W. T., A. Lal, I.-M. Siu, T. L. Loney, C. J. Wikstrand, M.
A. Marra, C. Prange, D. D. Bingner, R. L. Strausberg, and G. J.
Riggins. 2000. Identifying potential tumor markers and
antigens by database mining and rapid expression screening.
Genome Res. 10:1393–1402.
Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful
mammalian expression vector. Nucleic Acids Res. 18:
5322.
Nakamura, A., A. Ishii, C. Ohata, and T. Komurasaki. 2007. Early
induction of osteoactivin expression in rat renal tubular
epithelial cells after unilateral ureteral obstruction. Exp.
Toxicol. Pathol. 59:53–59.
Naumovski, L., and J. R. Junutula. 2010. Glembatumumab
vedotin, a conjugate of an anti-glycoprotein non-metastatic
melanoma protein B mAb and monomemthyl auristatin E for
the treatment of melanoma and breast cancer. Curr. Opin.
Mol. Ther. 12:248 –257.
Ogawa, T., T. Nikawa, H. Furochi, M. Kosyoji, K. Hirasaka, N.
Suzue, K. Sairyo, S. Nakano, T. Yamaoka, M. Itakura, et al.
2005. Osteoactivin upregulates expression of MMP-3 and
MMP-9 in ﬁbroblasts inﬁltrated into denervated skeletal
muscle in mice. Am. J. Cell Physiol. 289:697–707.
Onaga, M., A. Ido, S. Hasuike, H. Uto, A. Moriuchi, K. Nagata, T.
Hori, K. Hayash, and H. Tsubouchi. 2003. Osteoactivin
expressed during cirrhosis development in rats fed a
choline-deﬁcient, l-amino acid-deﬁned diet, accelerates
motility of hepatoma cells. J. Hepatol. 39:779–785.
Osamura, N., K. Ikeda, T. Ito, H. Higashida, K. Tomita, and S.
Yokoyama. 2005. Induction of interleukin-6 in dorsal root
ganglion neurons after gradual elongation of rat sciatic nerve.
Exp. Neurol. 195:61–70.
Owen, T., S. L. Smock, S. Prakash, L. Pinder, D. Brees, D. Krull, T.
A. Castleberry, Y. C. Clancy, S. C. Marks Jr, F. F. Safadi, et al.
2003. Identiﬁcation and characterization of the genes encoding
human and mouse osteoactivin. Crit. Rev. Eukaryot. Gene
Expr. 13:205–220.
Pahl, M. V., N. D. Vaziri, J. Yuan, and S. G. Adler. 2010.
Upregulation of monocyte/macrophage HGFIN
(Gpnmb/osteoactivin) expression in end-stage renal disease.
Clin. J. Am. Soc. Nephrol. 5:56–61.
Patel-Chamberlin, M., Y. Wang, B. Satirapoj, L. M. Phillips, C. C.
Nast, T. Dai, R. A. Watkins, X. Wu, R. Natarajan, A. Leng, et al.
2011. Hematopoietic growth factor inducible neurokinin-1
(Gpnmb/Osteoactivin) is a biomarker of progressive renal
injury across species. Kidney Int. 79:1138–1148.
c   2012 The Authors. Published by Wiley Periodicals, Inc. 95Gpnmb Expression in Normal and Inﬂamed CNS J.-J. Huang et al.
P o l l a c k ,V .A . ,E .A l v a r e z ,K . F .T s e ,M .Y .T o r g o v ,S .X i e ,S .G .
Shenoy, J. R. MacDougall, S. Arrol, H. Zhong, R. W. Gerwien,
et al. 2007. Treatment parameters modulating regression of
human melanoma xenografts by an antibody-drug conjugate
(CR011-vcMMAE) targeting GPNMB. Cancer Chemother.
Pharmacol. 60:423–435.
Q i a n ,X . ,E .M i l l s ,M .T o r g o v ,W .J .L a R o c h e l l e ,a n dM .J e f f e r s .
2008. Pharmacologically enhanced expression of GPNMB
increases the sensitivity of melanoma cells to the
CR011-vcMMAE antibody-drug conjugate. Mol. Oncol.
2:81–93.
Rakic, P. 2003. Elusive radial glial cells: historical and
evolutionary perspective. Glia43:19–32.
Rich, J. N., Q. Shi, M. Hjelmeland, T. J. Cummings, C.-T. Kuan,
D. D. Binger, C. M. Counter, and X.-F. Wang. 2003.
Bone-related genes expressed in advanced malignancies induce
invasion and metastasis in a genetically deﬁned human cancer
model. J. Biol. Chem. 278:15951–15957.
R i p o l l ,V .M . ,K .M .I r v i n e ,T .R a v a s i ,M .J .S w e e t ,a n dD .A .
Hume. 2007. Gpnmb is induced in macrophages by IFN-γ and
lipopolysaccharide and acts as a feedback regulator of
proinﬂammatory responses. J. Immunol. 178:6557–6566.
Rose, A. A. N., A.-A. Grosset, Z. Dong, C. Russo, P. A.
MacDonald, N. R. Bertos, Y. St-Pierre, R. Simantov, M.
Hallett, M. Park, et al. 2010b. Glycoprotein nonmetastatic B is
an independent prognostic indicator of recurrence and novel
therapeutic target in breast cancer. Clin. Cancer Res.
16:2147–2156.
Rose, A. A. N., and P. Siegel. 2010. Emerging therapeutic targets
in breast cancer bone metastasis. Future Oncol. 6:55–74.
Rose, A. A. N., M. G. Annis, Z. Dong, F. Pepin, M. Hallett, M.
Park, and P. M. Siegel. 2010a. ADAM10 releases a soluble form
of the GPNMB/osteoactivin extracellular domain with
angiogenic properties. PLoS One5:e12093.
S a f a d i ,F .F . ,J .X u ,S .L .S m o c k ,M .C .R i c o ,T .A .O w e n ,a n dS .N .
Popoff. 2002. Cloning and characterization of osteoactivin, a
novel cDNA expressed in osteoblasts. J. Cell. Biochem.
84:12–26.
Selim, A. A., J. L. Castaneda, T. A. Owen, S. N. Popoff, and F. F.
Safadi. 2007. The role of osteoactivin-derived peptides in
osteoclast differentiation. Med. Sci. Monit. 13:BR259–BR270.
S e l i m ,A .A . ,S .M .A b d e l m a g i d ,R .A .K a n a a n ,S .L .S m o c k ,T .A .
Owen, S. N. Popoff, and F. F. Safadi. 2003. Anti-osteoactivin
inhibits osteoblast differentiation and function in vitro.C r i t .
Rev. Eukaryot. Gene Expr. 13:265–275.
Selim, A. A. 2009. Osteoactivin bioinformatic analysis: prediction
of novel functions, structural features, and modes of action.
Med. Sci. Monit. 15:MT19–MT33.
Sheng, M. H.-C., J. E. Wergedal, S. Mohan, and K.-H. W. Lau.
2008. Osteoactivin is a novel osteoclastic protein and plays a
key role in osteoclast differentiation and activity. FEBS Lett.
582:1451–1458.
Shikano, S., B. Bonkobara, P. K. Zukas, and K. Ariizumi. 2001.
Molecular cloning of a dendritic cell-associated
transmembrane protein, DC-HIL, that promotes
RGD-dependent adhesion of endothelial cells through
recognition of heparan sulfate proteoglycans. J. Biol. Chem.
276:8125–8134.
Spassky, N., F.T. Merkle, N. Flames, A. D. Tramontin, J. M.
Garc´ ıa-Verdugo, and A. Alvarez-Buylla. 2005. Adult
ependymal cells are postmitotic and are derived from radial
glial cells during embryogenesis. J. Neurosci. 25:10–18.
Tomihari, M., J.-S. Chung, H. Akiyoshi, P. D. Cruz Jr, and K.
Ariizumi. 2010. DC-HIL/Glycoprotein nmb promotes growth
of melanoma in mice by inhibiting the activation of
tumor-reactive T cells. Cancer Res. 70:5778–5787.
T s e ,K .F . ,M .J e f f e r s ,V .A .P o l l a c k ,D .A .M c C a b e ,M .L .S h a d i s h ,
N. V. Khramtsov, C. S. Hackett, S. G. Shenoy, B. Kuang, F. L.
Boldog, et al. 2006. CR011, a fully human monoclonal
antibody-auristatin E conjugate, for the treatment of
melanoma. Clin. Cancer Res. 12:1373–1382.
Tyburczy, M. E., K. Kotulska, P. Pokarowski, J. Mieczkowski, W.
Grajkowska, M. Roszkowski, S. Jozwiak, and B. Kaminska.
2010. Novel proteins regulated by mTOR in subependymal
giant cell astrocytomas of patients with tuberous sclerosis
complex and new therapeutic implications. Am. J. Pathol.
176:1878–1890.
Valli` eres, L., and S. Rivest. 1997. Regularion of the genes
encoding interleukin-6, its receptor, and gp130 in the rat brain
in response to the immune activator lipopolysaccharide and
the proinﬂammatory cytokine intrleukin-1β.J .N e u r o c h e m .
69:1668–1683.
Wang, D. D., and A. Bordey. 2008. The astrocyte odyssey. Prog.
Neurobiol. 86:342–367.
Weterman, M. A. J., N. Ajubi, I. M. R. van Dinter, W. G. J. Degen,
G. N. P. van Muijen, D. J. Rutter, and H. P. J. Bloemers. 1995.
nmb, a novel gene, is expressed in low-metastatic human
melanoma cell lines and xenografts. Int. J. Cancer60:73–81.
Williams, M. D., B. Esmaeli, A. Soheili, R. Simantov, D. S.
Gombos, A. Y. Bedikian, and P. Hwu. 2010. GPNMB
expression in uveal melanoma: a potential for targeted therapy.
Melanoma. Res. 20:184–190.
Supporting Information
Additional Supporting Information may be found in the on-
line version of this article:
Figure. S1. Characterization of Gpnmb-IR cells in cortical
layer VI with multiple markers.
Figure. S2. Distribution of Gpnmb-IR in the olfactory bulb.
Figure. S3. Distribution of Gpnmb-IR in the striatum.
Table S1. Distribution of Gpnmb-immunoreactivity in the
Adult Rat Brain.
Pleasenote:Wiley-Blackwellisnotresponsibleforthecontent
or functionality of any supporting materials supplied by the
authors.Anyqueries(otherthanmissingmaterial)shouldbe
directed to the corresponding author for the article.
96 c   2012 The Authors. Published by Wiley Periodicals, Inc.